StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alnylam (ALNY) data is positive for Ionis (IONS), Intellia (NTLA) and negative for BridgeBio (BBIO) - analyst
June 24, 2024 7:58 AM
Alnylam Pharma (NASDAQ: ALNY) data is positive for Ionis Pharmaceuticals (NASDAQ: IONS) and Intellia Therapeutics (NASDAQ: NTLA) and negative for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA)
June 26, 2024 5:27 AM
Alnylam Pharmaceuticals (ALNY) PT Raised to $250 at Morgan Stanley
June 24, 2024 12:28 PM
Stifel on Intellia Therapeutics (NTLA): 'Positive Ph.3 HELIOS-B data this morning validates the NTLA-2001 approach'
June 24, 2024 12:15 PM
Raymond James on BridgeBio Pharma (BBIO): 'We expect the topline nominal win for HELIOS-B will send BBIO shares downward'
June 24, 2024 11:49 AM
RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'
June 24, 2024 11:38 AM
Evercore ISI on HELIOS-B Read-Through to BridgeBio Pharma (BBIO)
June 24, 2024 11:36 AM
Baird on Intellia Therapeutics (NTLA): 'we anticipate enthusiasm will wane'
June 24, 2024 9:49 AM
